Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05700760 · ClinicalTrials.gov registry record · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
A NA study of Postpartum Depression, sponsored by Michigan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 2,320
- Enrollment target
- 1
- Study location
NCT05700760 is a NA study of Postpartum Depression that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 2,320 participants, above the 474-participant average among 38 other Postpartum Depression trials with a reported enrollment target (389% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05700760, a NA study of Postpartum Depression, is actively recruiting participants, sponsored by Michigan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,320 participants
- Enrollment target
- 1
- Study location
Study Summary
The Reach Out, Stand Strong, Essentials for New Mothers (ROSE) program is an evidence-based intervention that prevents half of cases of postpartum depression and was one of two interventions recommended by the US Preventive Services Task Force in 2019. All effectiveness trials of ROSE and of the other recommended PPD prevention intervention included only low-income women a single risk factor that doubles incidence of PPD. Thus, the existing evidence base for PPD prevention consists primarily of women at increased risk for PPD. Based on data from the PIs' current implementation study of ROSE, many healthcare and community agencies in this implementation trial (78%) find it is more feasible for them to provide or offer ROSE to every woman as part of their standard workflow, than it is to create a screening and referral process for at risk women. In addition to being more feasible for agencies, universal prevention may also be advantageous because the cost of a screening false negative (resulting in a preventable case of PPD; $32,000) far exceeds the cost of ROSE delivery ($50-$300/woman). Effectiveness of ROSE among low-income women at risk for PPD is known (ROSE prevents \~50% of PPD cases). To inform a recommendation about using ROSE as universal vs. selective or indicated prevention, we need to determine the effectiveness of ROSE among general populations of women, including women screening negative for PPD risk. Thus, this project will assess ROSE effectiveness across PPD risk levels and across prevention approaches in a sample of 2,320 women from a large regional health system (based in Detroit, MI). Each proposed aim gathers a piece of information missing that is needed to guide decision-making about ROSE as universal prevention. We will assess ROSE as universal, selective, and indicated prevention in terms of: (1) ROSE effectiveness relative to a control for each prevention approach in preventing PPD and improving functioning; (2) cost outcome, (3) equity and (
Conditions Studied
Interventions
- BEHAVIORAL ROSE (Reach Out, Stay Strong, Essentials for mothers of newborns)
- BEHAVIORAL Enhanced Care as Usual (CAU)
Study Locations (1)
Michigan
- Michigan State University - Flint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,320 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05700760
The ClinicalTrials.gov registry entry for NCT05700760 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,320 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 474-participant average among 38 other Postpartum Depression trials with a reported enrollment target (389% higher). The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postpartum Depression appearing as the primary indexed condition, and to 2 interventions - of which ROSE (Reach Out, Stay Strong, Essentials for mothers of newborns) is the first listed.
NCT05700760 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05700760 about?
NCT05700760 is a clinical study titled "The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention". The Reach Out, Stand Strong, Essentials for New Mothers (ROSE) program is an evidence-based intervention that prevents half of cases of postpartum depression and was one of two interventions recommended by the US Preventive Services Task Force in 2019. All effectiveness trials of ROSE and of the oth...
What is the current status of trial NCT05700760?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,320 participants. The study started on 2023-06-01. Estimated completion is 2027-12-31.
What conditions does trial NCT05700760 study?
This clinical trial studies the following conditions: Postpartum Depression.
What interventions are being tested in trial NCT05700760?
The interventions under investigation include: ROSE (Reach Out, Stay Strong, Essentials for mothers of newborns) (BEHAVIORAL), Enhanced Care as Usual (CAU) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05700760?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05700760 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preventing Postpartum Depression in Immigrant Latinas
RECRUITING · NA
-
In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Maternal Mental Health Access - MaMa
RECRUITING · NA
-
The Mom and Infant Outcomes (MOMI) Study
RECRUITING · NA
-
Maternal Stress on Human Milk and Infant Outcomes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.